These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1588992)

  • 1. Synthetic surfactants in infants with respiratory distress syndrome.
    Perlman JM; Moya F
    N Engl J Med; 1992 Jun; 326(25):1703-4; author reply 1704-5. PubMed ID: 1588992
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic surfactant.
    Long W
    Semin Perinatol; 1993 Aug; 17(4):275-84. PubMed ID: 8140442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug treatments of respiratory distress syndrome in premature infants].
    Saliba E; Laugier J
    Pediatrie; 1993; 48(12):864-71. PubMed ID: 8047397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant and the neonatal lung.
    Gibson AT
    Br J Hosp Med; 1997 Oct 15-Nov 4; 58(8):381-4, 397. PubMed ID: 9509038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic surfactants in infants with respiratory distress syndrome.
    Egan EA
    N Engl J Med; 1992 Jun; 326(25):1704; author reply 1704-5. PubMed ID: 1588993
    [No Abstract]   [Full Text] [Related]  

  • 6. Surfactant for respiratory distress syndrome.
    Bierman SF
    N Engl J Med; 1989 Sep; 321(12):834. PubMed ID: 2671737
    [No Abstract]   [Full Text] [Related]  

  • 7. Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer?
    Chima RS; Zingarelli B
    Crit Care Med; 2007 Oct; 35(10):2442-3. PubMed ID: 17885382
    [No Abstract]   [Full Text] [Related]  

  • 8. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome.
    Hallman M; Merritt TA; Schneider H; Epstein BL; Mannino F; Edwards DK; Gluck L
    Pediatrics; 1983 Apr; 71(4):473-82. PubMed ID: 6340042
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the treatment of the respiratory distress syndrome in premature infants with tris(hydroxymethyl)-aminomethane (THAM) and wetting agents].
    Jarre W; Ketterle W; Reinwein H
    Helv Paediatr Acta; 1965 Apr; 20(1):27-39. PubMed ID: 5828973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Exogenous surfactant preparations].
    Helewski K; Kowalczyk-Ziomek G; Konecki J
    Pneumonol Alergol Pol; 1998; 66(1-2):127-32. PubMed ID: 9658893
    [No Abstract]   [Full Text] [Related]  

  • 12. RDS and surfactant replacement: the double-edged sword.
    Etherington H; Lawrence J; Davis D
    Can Nurse; 1993 Jan; 89(1):14-7. PubMed ID: 8425163
    [No Abstract]   [Full Text] [Related]  

  • 13. [Factors affecting clinical response to surfactant therapy in neonates with severe respiratory distress syndrome].
    Fujiwara T; Chida S; Konishi M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):29-34. PubMed ID: 2041254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New avenues in surfactant research.
    Robertson B
    Z Geburtshilfe Neonatol; 2001; 205(3):77-8. PubMed ID: 11474993
    [No Abstract]   [Full Text] [Related]  

  • 15. Urine output in infants with respiratory distress syndrome treated with surfactant.
    Hamdan AH; Shaw NJ
    Clin Pediatr (Phila); 2000 Jul; 39(7):421-5. PubMed ID: 10914308
    [No Abstract]   [Full Text] [Related]  

  • 16. Artificial surfactant to prevent and treat neonatal respiratory distress syndrome.
    Enhorning G
    Pediatrics; 1980 Nov; 66(5):799-800. PubMed ID: 7432889
    [No Abstract]   [Full Text] [Related]  

  • 17. Fifth time's the charm for infant respiratory distress drug.
    Katsnelson A
    Nat Biotechnol; 2012 May; 30(5):380. PubMed ID: 22565949
    [No Abstract]   [Full Text] [Related]  

  • 18. Inactivation of pulmonary surfactant and the treatment of acute lung injuries.
    Taeusch HW; Keough KM
    Pediatr Pathol Mol Med; 2001; 20(6):519-36. PubMed ID: 11699577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Membrane syndrome (respiratory distress syndrome) in newborn infants. Pathogenesis and therapy with special regard to alveolar surface active agent].
    Keuth U
    Fortschr Med; 1973 Jun; 91(16):693-7. PubMed ID: 4740218
    [No Abstract]   [Full Text] [Related]  

  • 20. Does surfactant therapy prolong dying? Age at in-hospital death of extremely premature babies.
    Coulter DM; Jung AL
    J Perinatol; 1996; 16(3 Pt 1):166-70; quiz 171-2. PubMed ID: 8817423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.